Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

por Cullum, Christopher Kjaer, Do, Thien Phu, Ashina, Messoud, Bendtsen, Lars, Hugger, Sarah Sonja, Iljazi, Afrim, Gusatovic, Julia, Snellman, Josefin, Lopez-Lopez, Cristina, Ashina, Håkan, Amin, Faisal Mohammad
Publicado 2022